Alfresa Holdings Corporation Stock

Equities

2784

JP3126340003

Medical Equipment, Supplies & Distribution

Delayed Japan Exchange 11:37:44 2024-05-08 pm EDT 5-day change 1st Jan Change
2,404 JPY +0.80% Intraday chart for Alfresa Holdings Corporation +0.65% +0.38%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2024 * 2,853B 18.34B Sales 2025 * 2,850B 18.32B Capitalization 446B 2.87B
Net income 2024 * 27.79B 179M Net income 2025 * 26.52B 170M EV / Sales 2024 * 0.16 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.16 x
P/E ratio 2024 *
16.2 x
P/E ratio 2025 *
16.9 x
Employees 11,772
Yield 2024 *
2.89%
Yield 2025 *
2.8%
Free-Float 84.72%
More Fundamentals * Assessed data
Dynamic Chart
Alfresa Holdings Corporation Revises Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Alfresa Holdings Corporation Revises Consolidated Earnings Guidance for the Full Year Ending March 31, 2024 CI
Alfresa Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Alfresa Holdings Corporation Provides Commemorative Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Alfresa Holdings Corporation Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2024 CI
Alfresa Holdings Corporation Revises Consolidated Earnings Guidance for the First Half Ended September 30, 2023 and Fiscal Year March 31, 2024 CI
Alfresa Holdings Completes 35 Billion Yen Share Buyback program MT
Tranche Update on Alfresa Holdings Corporation's Equity Buyback Plan announced on May 15, 2023. CI
Tranche Update on Alfresa Holdings Corporation's Equity Buyback Plan announced on May 15, 2023. CI
Alfresa Holdings Corporation's Equity Buyback announced on May 15, 2023, has closed with 15,201,200 shares, representing 7.65% for ¥34,999.80 million. CI
Alfresa unit Cell Resources Partners with Miltenyi Biotec to Advance Cell Culture Automation in Gene Cell Therapy Market MT
Alfresa Holdings Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year Ending March 31, 2024 CI
Alfresa Holdings Corporation Provides Dividend Guidance for the Second Quarter and Year End of Fiscal Year Ending March 31, 2023 CI
Tranche Update on Alfresa Holdings Corporation's Equity Buyback Plan announced on May 15, 2023. CI
Alfresa Plans up to 35 Billion Yen Share Buyback; Shares Up 6% MT
More news
1 day+0.84%
1 week+0.65%
Current month+2.98%
1 month+8.82%
3 months+4.66%
6 months-3.20%
Current year+0.38%
More quotes
1 week
2 364.00
Extreme 2364
2 409.00
1 month
2 133.00
Extreme 2133
2 409.00
Current year
2 133.00
Extreme 2133
2 554.50
1 year
1 997.00
Extreme 1997
2 643.50
3 years
1 505.00
Extreme 1505
2 643.50
5 years
1 505.00
Extreme 1505
2 986.00
10 years
1 281.00
Extreme 1281
3 350.00
More quotes
Managers TitleAgeSince
Director of Finance/CFO 64 18-03-31
President 61 07-05-31
Compliance Officer - -
Members of the board TitleAgeSince
Director/Board Member 47 20-05-31
President 61 07-05-31
Director/Board Member 70 20-05-31
More insiders
Date Price Change Volume
24-05-08 2,404 +0.80% 158 300
24-05-08 2,386 +0.51% 434,600
24-05-07 2,374 -0.69% 299,300
24-05-02 2,390 +1.68% 605,300
24-05-01 2,350 +0.62% 644,000

Delayed Quote Japan Exchange, May 08, 2024 at 11:37 pm EDT

More quotes
Alfresa Holdings Corporation is a Japan-based holding company primarily engaged in the wholesale of drugs. The Company operates in four business segments. The Pharmaceutical Wholesale segment is engaged in the wholesale of medical products, test reagents, as well as medical equipment and materials. The Self Medication Wholesale segment is engaged in the wholesale of general drugs. The Pharmaceutical Manufacture segment is engaged in the manufacture and sale of pharmaceuticals, test reagents, medical equipment and implements, as well as pharmaceutical powders. The Medical-Related segment is mainly engaged in operation of pharmacies. The others business is engaged in the information system business, the transportation business, the warehousing business, the insurance agency business, the real estate management business, the sale of miscellaneous goods, as well as the manpower dispatching business, among others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
2,386 JPY
Average target price
2,288 JPY
Spread / Average Target
-4.11%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW